Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 98Stomach Neoplasms 50Rectal Neoplasms 45Pancreatic Neoplasms 45Colonic Neoplasms 36Esophageal Neoplasms 34Neoplasms 30Neoplasm Metastasis 28Squamous Cell Carcinoma of Head and Neck 27Head and Neck Neoplasms 24Breast Neoplasms 21Adenocarcinoma Of Esophagus 20Parkinson Disease 4, Autosomal Dominant Lewy Body 12Adenocarcinoma 9Anus Neoplasms 8Esophageal Squamous Cell Carcinoma 7Carcinoma, Squamous Cell 7Carcinoma 7Cholangiocarcinoma 6Liver Neoplasms 5Gallbladder Neoplasms 5Bile Duct Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Adenocarcinoma 4Gastrointestinal Neoplasms 4Carcinoma, Hepatocellular 4Skin Neoplasms 3Sarcoma 3Peritoneal Neoplasms 3Laryngeal Neoplasms 3

Interventions

tislelizumab 1Taxes 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Fluorouracil 1Etoposide 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Locally Advanced and Metastatic Solid Tumors × Fluorouracil × Clear all
NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeiGene

Phase 1 Completed
446 enrolled 49 charts
Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡